Im becky quick along with joe kerr de kernen and Andrew Ross Sorkin. After two days of optimism, the get out there again trade was on turned around a little bit yesterday. We did see people rushing back to the stayathome stocks as covid cases and momentization hs continue to climb. And some states are imposing restrictions and the nasdaq ended up 2 after being down monday and tuesday. Yesterday the dow ended flat, right now indicated down by about 115. Never made to the record, still waiting circumstanling around tt s p 500 down by 2. 5 and nasdaq indicated up another 51 points this morning these were the stay at home stocks, amazon up, apple up 3 , zoom which had gotten hammered, yesterday up by almost 10 took c docusign 5. 2 and netflix 2. 2 and treasury yields, yesterday it was closed for veterans day this morning it is open and you can see the ten year still around the very heightened levels, again, not historically, but based on what weve seen in recent history within range of 1 a
And too early for the bears to start thinking about hibernation. Julia, a cool breeze from snap indeed. Well kick off todays feed with the ad market slowdown snap plunging this morning after missing estimates and reporting its slowest Revenue Growth ever and the ceo blaming the bliss on platform policy changes and increasing competition for ad dollars warning it will likely take some time before we see significant improvements and when you factor in twitter and a surprise loss driven by, you guessed it, a weakening ad market, many investors wondering this morning what it means for the likes of meta, google and more companies that are reporting next week and the following. You know, jon, we were talking about this earlier, but i have to say i know there are these broader Macro Economic pressures and i do expect to see some impact on all of the different adsupported players and the real question here is who is best positioned . There was a really interesting note from baird this morning
Chemists and biologists are working to create effective treatments for coronavirus. At some point they will likely develop a vaccine for it. That could be a year from now. In the meantime, researchers are taking a second look at drugs already in use for other diseases, and there have been we are happy to tell you some Promising Development so far. A japanese antiviral drugs been used to treat influenza among other things. In early Clinical Trial in china showed improved outcomes for those with mild cases of coronavirus. Remdesivir is a drug originally created to fight the ebola. Scientist said has shown promise too. So have two other hiv drugs. Theres medications are being studied now overseen by the World Health Organization. Here in our country, a drug called hydroxychloroquine has received by far the most attention. Hydroxychloroquine is most commonly used as an antimalarial medicine. You may have taken it if youve taken it abroad. Its been proved in this country for 65 years. Its c
MSP Recovery, Inc. (NASDAQ:LIFW – Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 183,700 shares, a decrease of 21.1% from the April 30th total of 232,900 shares. Currently, 1.4% of the company’s shares are sold short. […]
MSP Recovery, Inc. (NASDAQ:LIFW – Get Free Report) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 183,700 shares, a decline of 21.1% from the April 30th total of 232,900 shares. Based on an average daily trading volume, of 2,150,000 shares, the short-interest […]